Stock Analysis · Bulls vs Bears

Almonty Industries ALM

🐂 Bulls vs Bears 🐻Report #211 Oct 2026
★ Willem owns this stock · 3.9% of the portfolioOlder version — see the latest →
59
high risk▼ −9 vs last
🐂 7vs9 🐻
Bears lead
28%
▲ Chance of the biggest tailwind the forecasts miss
38%
▼ Chance of the biggest headwind the forecasts miss
The verdict

Almonty owns what is probably the most strategic new Western tungsten mine at a time when policy has made Western tungsten scarce, it is funded, and its offtake has a floor and no cap. But today it is still a small Portuguese mine plus a promise. Forecasts already assume a steep Sangdong ramp at high prices, while the company has published no operating number and has a record of missed timelines.

🎙️ Bulls vs Bears podcast — Almonty Industries
Alex and Sam debate every bull and bear argument · 11:32
0:0011:32
⤓ Download

Written by Claude (Anthropic’s AI) from public sources · Willem owns ALM · AI can make mistakes — numbers in brackets point to the sources · Not financial advice

🐂 Bull arguments 7

  1. 1Policy has created a protected Western price, and Sangdong is the largest new supply aimed at itStrong
  2. 2A long contract with a floor and no capStrong
  3. 3The balance sheet removes financing risk for this phaseStrong
  4. 4Cost far below price, already visible at PanasqueiraMedium
  5. 5Growth pipeline beyond Phase IMedium
  6. 6A natural fit for US stockpiling and government supportWeak
  7. 7Buyback at scale signals confidenceWeak

🐻 Bear arguments 9

  1. 1Sangdong's ramp is unproven, and starts on low-grade oreHigh
  2. 2Revenue is a direct bet on a policy-made price that is already easingHigh
  3. 3A track record of over-promising, weak controls and a fresh auditor swapMedium
  4. 4Concentrated customers, and a customer that is also a seller of the stockMedium
  5. 5Expectations already assume a steep ramp at high pricesMedium
  6. 6Insiders and early backers have been selling; no insider buyingLow
  7. 7The only cash engine today is shrinkingLow
  8. 8Capital spending is undisclosed and capital allocation is unprovenMedium
  9. 9Korea-specific operating riskLow

Bull arguments show how well they survive the devil’s advocate (strong / medium / weak); bear arguments show the damage they could do after the counter-argument (high / medium / low).

Bull case — all positive points (most important first)

🐂 Bull #1Policy has created a protected Western price, and Sangdong is the largest new supply aimed at it

  • The point: China's export licensing and the US defence ore-origin rule split tungsten into a cheap Chinese market and a scarce, expensive Western one. Almonty sells into the expensive one.
  • Evidence:
    • China mined ~79% of world tungsten in 2025 [24].
    • China's licensing from 2025-02-04 cut APT exports ~70% in Jan–Nov 2025 and to zero in Jan–Feb 2026 [27].
    • On ~2026-10-09, APT CIF Rotterdam was US$2,700–3,100/mtu. Chinese 65% concentrate was ~US$738/mtu CIF China [25].
    • Long-term smelter contracts in Europe and the US are still reported above US$3,000/mtu [25].
    • DFARS 225.7018-2 extends the ban on covered-nation tungsten (China, Russia, North Korea, Iran) back to "mining or production of a tungsten ore" from 2027-01-01 [28].
    • Platts has proposed CIF-US-port APT and concentrate prices from 2026-11-30, naming South Korea as an eligible origin [32].
  • Why it matters:
    • At ~US$2,400/mtu realised (89% of US$2,700), 210,000 mtu is roughly US$500M a year of Sangdong revenue (our arithmetic). The company's own figure is "US$490M a year at current APT" [7].
    • Once DoD primes must trace ore, buyers with a legal need may pay up for a source like this.
  • 😈 Devil's advocate:
    • The premium is a policy artefact. China extended its trade truce with the US to 2027-01-10 [37] and could license more exports.
    • DFARS has waivers for non-availability and national security [29].
    • SMM expects new non-China APT capacity in 2027 to narrow the spread [25].
    • The Western market is thin: spot APT and oxide trading in Europe and the US was "nearly zero for a quarter" [25].
  • Verdict: Strong This is the core of the case. But it is a policy bet, and the policy can move either way.

🐂 Bull #2A long contract with a floor and no cap

  • The point: Most of Sangdong's output is sold for two decades at spot-linked prices, with downside protection.
  • Evidence:
    • Amended 2026-07-14: 21 years, 4.41M mtu, +6.3% price, ≥US$30M/yr extra at current APT [7].
    • Minimum 210,000 mtu/yr; floor US$183/mtu concentrate; no cap [6].
    • Plansee and Almonty are joint obligors [6].
    • Separate floor-priced deals: molybdenum with SeAH (US$19/lb) [6] and Los Santos tailings take-or-pay with Sandvik [14].
  • Why it matters: volume risk (finding a buyer) is gone at a time when other ex-China miners "cannot find buyers" [25]. Upside to price is kept.
  • 😈 Devil's advocate:
    • The floor is about 92% below today's price, so it protects only against a total collapse.
    • One buyer takes ~90%.
    • GTP's right of first refusal at lower prices limits Almonty's ability to sell surplus to the highest bidder [1].
    • Plansee sold 2.5M shares while negotiating the extension [21].
    • The revised formula is not public, so the "+6.3%" cannot be checked against a benchmark.
  • Verdict: Strong for revenue certainty. Medium for value, because it removes the chance to capture any future Western premium above the European APT quote.

🐂 Bull #3The balance sheet removes financing risk for this phase

  • The point: Almonty can build Phase II and the oxide plant without a new equity raise at a bad time.
  • Evidence:
    • Cash C$1,227M and working capital C$1,127M at 2026-06-30 [3].
    • US$800M 2.25% notes due 2031 convert at US$27.40, 32.5% above the US$20.68 reference [11].
    • A capped call between US$27.40 and US$41.36 (cost US$94.8M) offsets dilution in that range [4].
    • Warrants outstanding fell to 4,000 [3].
    • H1-26 operating cash flow was +C$31.6M [4].
  • Why it matters: many critical-mineral peers must raise equity on poor terms. Almonty can wait out a weak tungsten year.
  • 😈 Devil's advocate:
    • The cash is borrowed. Undiscounted principal due in 2031 is ~C$1.2B, and the Sangdong KfW loan (C$136.4M at 2026-06-30) starts amortising six months after ramp-up [3].
    • Net cash is modest once both are counted.
    • The MD&A still says the company can operate "for a minimum of 15 months" on "non-contingent financial resources", an odd phrase next to C$1.2B [3].
    • US$543M was earmarked for general corporate purposes "including possible acquisitions" [11].
  • Verdict: Strong The main residual risk is how the cash is spent, not whether it exists.

🐂 Bull #4Cost far below price, already visible at Panasqueira

  • The point: Even an old, shrinking mine makes ~60% gross margins at today's prices. A bigger, lower-cost Sangdong should do better.
  • Evidence:
    • Q2-26 cost of sales was 39.3% of revenue, a 60.7% gross margin [2].
    • Sangdong's technical report: LOM cash cost US$126.8/mtu and AISC US$136.3/mtu at plan grade; no Korean royalty; 23.1% tax [1].
  • Why it matters: at ~US$2,400 realised, even a several-fold cost overrun would leave large per-unit margins.
  • 😈 Devil's advocate:
    • The report's US$47.51/t ore operating cost at a 0.25% stockpile grade and 85% recovery works out to ~US$223/mtu (our arithmetic).
    • The plan assumed US$450 APT and has never been tested in operation.
    • G&A doubled to C$16.0M in H1 [4].
    • Royalty costs jumped to C$6.97M in Q2, unexplained [3].
    • Black says US operations cost "twice" Europe's [10].
  • Verdict: Medium The margin cushion is real at current prices, but there are zero Sangdong cost data points.

🐂 Bull #5Growth pipeline beyond Phase I

  • The point: Phase II could double Sangdong. The oxide plant moves Almonty into a higher-value product.
  • Evidence:
    • Phase II is "officially a go", underground development has started, and mill orders were placed or are coming within 4–6 weeks [9,10].
    • Phase II is fully permitted under the Phase I approvals [3].
    • Oxide plant: 4,000 t/yr WO3 at Yeongwol, with construction hoped for Q1–Q2 2027 [10].
    • Plus Gentung (US), Rwanda (75%) and Los Santos tailings [14,23].
  • Why it matters: Phase II is not covered by the GTP contract, so its output could be sold to US defence buyers at any Western premium.
  • 😈 Devil's advocate:
    • Phase II and oxide capex are not disclosed anywhere.
    • Phase II was approved before Phase I had shipped a tonne. The MD&A itself made it "subject to positive operating results from Phase I" [3].
    • Oxide for chip-gas (WF6) needs 18–24 months of customer requalification [36].
    • The molybdenum deposit is Inferred only, and only 17–20% recovered into the tungsten circuit in tests [1].
  • Verdict: Medium for Phase II, Weak for the rest. It is real optionality without a budget.

🐂 Bull #6A natural fit for US stockpiling and government support

  • The point: Washington is spending to build non-China tungsten supply. Almonty is the most advanced allied producer.
  • Evidence:
    • DLA awarded Elmet a US$2B-ceiling contract for tungsten concentrate and sodium tungstate for the stockpile (2026-09-11), plus US$450M of preferred equity [31].
    • Elmet's US supply depends on mines and an APT restart not due before 2028–29 [31].
    • A US BIS order keeps US tungsten scrap at home from 2026-08-27 [30].
    • Almonty's Rwanda deal came via a US State Department introduction [23].
  • Why it matters: a US offtake or financing would validate and reprice the Western premium.
  • 😈 Devil's advocate:
    • No DoD, EXIM or DFC deal with Almonty has been found.
    • Most of Sangdong Phase I is already committed to GTP for 21 years, so Almonty has little to offer a US buyer until Phase II.
  • Verdict: Weak to Medium. It is optionality, not evidence.

🐂 Bull #7Buyback at scale signals confidence

  • The point: management is buying back stock.
  • Evidence:
    • US$300M or 14.4M shares authorised for 2026-08-24 to 2029-08-24 [12].
    • 2,914,739 shares were bought and cancelled for ~US$48M by 2026-09-29 [9].
  • Why it matters: it offsets option and convert dilution.
  • 😈 Devil's advocate:
    • It is funded with convert money while the company has negative free cash flow.
    • The average buy price of ~US$16.5 is above today's ~US$12.
    • Insiders were sellers at the same time (Bear #6).
  • Verdict: Weak

Bear case — all negative points (most important first)

🐻 Bear #1Sangdong's ramp is unproven, and starts on low-grade ore

  • The point: the whole value case rests on one plant that has published no operating data.
  • Evidence:
    • Sangdong revenue in H1-26 was C$0.12M [3].
    • The plant runs ~16 h/day, adding 2 hours "every few days" [10].
    • Three slurry pipes were "damaged during installation", causing a water-treatment overflow [10].
    • Feed is a ~139,700 t stockpile at ~0.25% WO3, about 4.6 months of feed [9].
    • Our arithmetic: 230,000 mtu/yr from 640 kt at 85% recovery needs ~0.42% feed. At 0.25% the plant would make ~136,000 mtu/yr, below GTP's 210,000 minimum. The minimum only applies after the 12-month ramp, though.
    • No recovery number has been published. The plan assumes 85% [1].
    • Goldman expects a "more gradual" ramp than the market [38].
  • Why it matters:
    • Consensus 2026 revenue is in the C$324–420M range on aggregators [50], and BofA had C$670M for 2026 in May [45].
    • H1 was C$68M.
    • Slippage hits the stock directly and pushes out Phase II.
  • 🛡️ Counter-argument:
    • Low-grade ore is a normal, deliberate commissioning choice.
    • The certificates are done.
    • The CEO says recoveries match expectations [10].
    • Development ore at 0.35% is already being mined [9].
  • Severity: High Q3 and Q4 results will be the first real test.

🐻 Bear #2Revenue is a direct bet on a policy-made price that is already easing

  • The point: a ~6x price move, not volume, drives everything, and the price is softening.
  • Evidence:
    • European APT averaged US$3,075 in Q2 [2]. It was ~US$2,700 per the CEO on 2026-10-07 [10] and US$2,700–3,100 (avg US$2,900) per SMM on ~10-09 [25].
    • China APT long-term contract prices fell from 600,000 yuan/t in early September to a forecast 550,000 for October [26].
    • China's APT operating rate hit a record low of ~49% in September [26].
    • Signs of demand destruction and substitution: cermets, tool redesign, molybdenum in special steels [26].
    • Japan's DIJET is exiting some carbide lines [25].
    • SMM expects new ex-China APT capacity in 2027 to narrow the spread [25].
    • The US–China truce has been extended to 2027-01-10 [37].
  • Why it matters: each US$10 of APT is ~US$8.90/mtu. Going from US$2,900 to US$1,500 APT would cut Sangdong contract revenue by ~US$260M/yr at 210,000 mtu (our arithmetic).
  • 🛡️ Counter-argument:
    • The China weakness is mostly a Chinese smelter-margin squeeze. Western prices have drifted, not collapsed.
    • The 2027 DFARS rule creates legally mandated demand.
    • Black says there is no demand destruction [10].
  • Severity: High No contract term protects against a fall to, say, US$1,500.

🐻 Bear #3A track record of over-promising, weak controls and a fresh auditor swap

  • The point: timelines and disclosure quality have repeatedly disappointed.
  • Evidence:
    • Sangdong production was first expected in 2022 [49] and arrived in 2026.
    • The company said "commissioned and producing" on 2026-03-16 [16], but the plant processed ore only from June [8].
    • Disclosure controls were "not effective" at 2026-06-30 because of a continuing material weakness (segregation of duties, close-process data integrity). Remediation assessment is expected in Q3 2026 [3].
    • ICFR was also ineffective at year-end 2019 and 2025 [1].
    • Zeifmans resigned at the company's request on 2026-09-29 and PwC was appointed. There was no disagreement [13].
    • The CFO changed after nine months [18].
    • The 15M-share debt-conversion and option issuance lifted the share count from 262.8M to 288.5M in 2026 [3].
  • Why it matters: investors can't yet rely on management dates, and the first Sangdong numbers will come through a new auditor and a weak control environment.
  • 🛡️ Counter-argument:
    • Moving to PwC is an upgrade suited to a Russell 1000 company. The outgoing auditor reported no disagreements or reportable events [13].
    • Mining start-ups commonly slip.
  • Severity: Medium

🐻 Bear #4Concentrated customers, and a customer that is also a seller of the stock

  • The point: one buyer takes ~90% of Sangdong, and two take most of Panasqueira.
  • Evidence:
    • GTP takes >90% of Phase I for 21 years, with a right of first refusal at lower prices on the rest [1,7].
    • Panasqueira has two main customers on annual contracts; the AIF says "economically dependent" [1].
    • Plansee sold 2.5M shares on 2026-02-27 [21].
    • Only 3–4 non-Chinese APT smelters exist [25].
  • Why it matters:
    • A dispute with, or financial trouble at, Plansee/GTP would leave Sangdong with few alternative buyers.
    • The contract caps Almonty's share of any future US premium on Phase I volume.
  • 🛡️ Counter-argument: Plansee is a large, private, century-old Austrian group. It is a joint obligor and guaranteed Sangdong's KfW lines [6], so its interests are aligned.
  • Severity: Medium

🐻 Bear #5Expectations already assume a steep ramp at high prices

  • The point: the forecasts leave little room for delay.
  • Evidence:
    • Aggregator consensus for 2026 is C$324–420M of revenue, versus H1 of C$68.4M [3,50]. BofA had C$670M (May) [45].
    • Mean target ~US$24 (MarketBeat), against a ~US$12 price [43].
    • Diamond Equity cut its FY26 EPS estimate from US$0.55 to US$0.39 (2026-08-19) [46].
    • Q2 EPS was flattered by a C$204M gain on the convert's conversion-feature derivative, which reverses if the share price rises [4].
  • Why it matters:
    • Sangdong's first export vessel sails 2026-10-24, so Q4 will show only a few weeks of Sangdong sales.
    • 2026 numbers are likely to miss consensus. Interpretation: the stock's slide from US$24 to US$12 may partly price this in.
  • 🛡️ Counter-argument:
    • Many targets were set before the drop. The stock already trades at about half the April peak.
    • Goldman's US$13 target is close to the current price, so the bear case is not obviously unpriced.
  • Severity: Medium

🐻 Bear #6Insiders and early backers have been selling; no insider buying

  • The point: the people closest to the asset cut exposure in 2026.
  • Evidence:
    • A Form 144 for 5,000,000 shares (~US$84.65M, ~US$16.93/share) via Almonty Partners LLC (Black/D'Amato), filed 2026-03-23. Whether it was executed was not found [19,20].
    • Plansee sold 2.5M shares [21].
    • Director Trachuk sold 200,000 shares at US$24.07 on 2026-07-02 [44].
    • Deutsche Rohstoff booked a €128M profit on a partial sale (aggregator).
    • Kyungrok Kwon sold small lots in late August 2026 at ~US$18.6. The "September" filings in our last notes could not be confirmed [35].
    • No open-market insider buys were found.
    • Short interest is ~11.2% of free float (Ortex, 2026-09-19) [42].
  • Why it matters: it signals that insiders saw the April price as full, and it adds supply to the market.
  • 🛡️ Counter-argument:
    • Black still holds ~15.1M shares directly [1].
    • The sales were at US$17–24, well above today.
    • Without SEDI we cannot separate plan sales from discretionary ones.
  • Severity: Low to Medium.

🐻 Bear #7The only cash engine today is shrinking

  • The point: Panasqueira volumes are falling while Sangdong is not yet earning.
  • Evidence:
    • Q2 production −20.8% y/y and H1 −17.6%, due to less ore mined and processed [3].
    • The L4 extension (to 800 kt, 0.19% head grade) is not yet built [5].
  • Why it matters: if APT falls before Sangdong ramps, there is no volume growth to offset it.
  • 🛡️ Counter-argument: Panasqueira is small next to Sangdong, so its decline matters less once Sangdong ships.
  • Severity: Low

🐻 Bear #8Capital spending is undisclosed and capital allocation is unproven

  • The point: large commitments have no published budgets.
  • Evidence:
    • No Phase II or oxide capex has been published. The only figures are a 2024 MOU of ~KRW40bn for plant upgrades and a preliminary ~KRW100bn for oxide [1].
    • US$67.5M of IPO money earmarked for oxide is unspent [3].
    • US$543M of convert proceeds is for general purposes "including possible acquisitions" [11].
    • Buyback at ~US$16.5 average [9].
  • Why it matters: an acquisition at peak tungsten prices, or a Phase II overrun, would burn the cushion that Bull #3 relies on.
  • 🛡️ Counter-argument: the cash is large relative to any plausible capex for these projects. The MOU figures suggest tens of millions, not hundreds.
  • Severity: Medium

🐻 Bear #9Korea-specific operating risk

  • The point: a single-country, single-mine project is exposed to local politics.
  • Evidence:
    • The Mining Industry Act lets the minister revoke rights in the public interest [3]. North Korea tension is a stated risk [1].
    • A forum post citing a Gangwon regional paper says work stopped on 2026-06-24/25 over a dispute with residents about jobs and catering, and later resumed [47]. UNCONFIRMED.
  • Why it matters: any stoppage at Sangdong stops the thesis.
  • 🛡️ Counter-argument: Korea is a stable democracy that wants domestic tungsten for its chip industry [36]. The project has full permits.
  • Severity: Low

Tailwinds NOT in the forecasts

  • A formal Western-origin premium above European APT — 28% chance within 36 months · Impact if it happens: High

    • What it is: contracts for non-Chinese, traceable concentrate settle at a published premium. The trigger would be the Platts CIF-US benchmark plus the DFARS 2027 rule. Phase II volume, which GTP does not cover, could then be sold at that premium.
    • Why it's not priced in:
      • Consensus is built on the European APT quote.
      • Goldman expects prices to normalise [38].
      • Platts is only a proposal [32].
    • What would trigger it / the sign to watch:
      • Platts finalises the CIF-US assessment for 2026-11-30.
      • It prints a premium to Rotterdam.
      • Almonty signs a Phase II or oxide offtake priced off it.
    • Why this probability: the legal driver is fixed on 2027-01-01, but waivers and a thin market make a durable, published premium less than a one-in-three outcome.

  • Phase II built on time in 2027 — 30% chance · Impact: High

    • What it is: Sangdong reaches the ~1.2 Mt/yr scale (target "over 460,000 mtu/yr") by end-2027.
    • Why it's not priced in:
      • Goldman sees a slower ramp.
      • No capex has been published, and Phase I itself is not yet at 24/7 [10,38].
    • What would trigger it / the sign to watch:
      • Metso mill order disclosed with a cost.
      • Phase I running 24/7 by early 2027.
    • Why this probability: a one-year build on a site where Phase I took five years is ambitious. Permits and some oversized components help.

  • A US government offtake, stockpile sale or financing with Almonty — 24% chance · Impact: Medium

    • What it is: DLA, DoW or EXIM takes Phase II or oxide product, or funds the oxide plant, as it did for Elmet [31].
    • Why it's not priced in: no such talks have been disclosed.
    • What would trigger it / the sign to watch:
      • A DLA tender won by Almonty.
      • Oxide offtake upsized with a US agency.
    • Why this probability: US demand is real and Almonty is the obvious allied supplier. But Phase I is committed to GTP, and the US has so far backed domestic players.

Headwinds NOT in the forecasts

  • Sangdong Phase I below 60% of capacity (138,000 mtu/yr) through end-2027 — 38% chance within 36 months · Impact if it happens: High

    • What it is: a combination of low stockpile grade, recovery below 85% and mechanical teething.
    • Why it's not priced in: consensus revenue implies a fast ramp [45,50].
    • What would trigger it / the sign to watch:
      • Q4-26 and Q1-27 Sangdong mtu sold.
      • Any disclosure of recovery below 80%.
      • Running hours still below 24/7 at year-end.
    • Why this probability: the 0.25% feed alone puts early output near 60% of nameplate, and new tungsten plants often take more than a year to stabilise. Development ore at 0.35% and management's recovery comment pull it below even odds.

  • Western APT falls below US$1,500/mtu for a full quarter — 22% chance · Impact: High

    • What it is: China eases licensing after the truce, new ex-China APT capacity arrives in 2027, and substitution spreads.
    • Why it's not priced in: sell-side targets assume elevated prices, though Goldman's normalisation call is partly there [38].
    • What would trigger it / the sign to watch:
      • MOFCOM licence approvals for the US or EU.
      • Rotterdam APT below US$2,000.
      • The China–West spread narrowing below US$1,000/mtu.
    • Why this probability: DFARS and stockpiling put a floor under Western demand. But China has every incentive to undercut Western mines once they are built, and the price is already ~6x the 2024 level.

  • Phase II capex overrun or slip into 2028+ — 45% chance · Impact: Medium

    • What it is: a common mining outcome, made more likely by an undisclosed budget and the Phase I history.
    • Why it's not priced in: guidance is "2027" [3].
    • What would trigger it / the sign to watch: the capex number when first disclosed, and mill delivery dates.
    • Why this probability: Phase I slipped about four years, so close to even odds that Phase II slips at least one year.

  • A restatement or late filing tied to the material weakness and auditor change — 12% chance · Impact: Medium

    • What it is: PwC's first audit, FY2026 due ~March 2027, finds issues, for example in derivative accounting.
    • Why it's not priced in: this is not discussed in the coverage found.
    • What would trigger it / the sign to watch:
      • The Q3 MD&A controls conclusion.
      • Any delay in Q3 or FY results.
    • Why this probability: ICFR has been weak for years, and the derivative accounting is complex, but there are no signs of misstatement so far.

Investment Risk Score: 59/100

Risk area Weight Score (0–100) Why
Business & competition 25% 55 It is a price-taker on a policy-made price. Western refining is the bottleneck, and Boguty and Nui Phao are larger or comparable. The asset is scarce and permitted.
Financial health & dilution 20% 40 C$1.23B cash. The convert (~29M shares at US$27.40) is offset by the capped call to US$41.36, and warrants are gone. The KfW project loan is still due, FCF is negative and shares are +10% in 2026.
Execution (delivering the plan) 20% 72 The plant runs 16 h/day on 0.25% ore. No throughput, recovery or cost data. About four years late versus the original target. Phase II has no capex budget.
Dependency & concentration 15% 72 One mine, one commodity, one buyer for ~90% of Sangdong. Two buyers at Panasqueira. Only 3–4 Western APT smelters.
Regulation, policy & geopolitics 10% 60 Value depends on China's licensing and US DFARS policy, both of which can swing. Korean revocation power.
Sentiment & expectations 10% 62 Consensus revenue and targets assume a fast ramp. Partly offset by the −51% fall and Goldman's US$13 target.

Overall = the weighted average: 13.75 + 8.0 + 14.4 + 10.8 + 6.0 + 6.2 = 59 (high).

Execution and concentration dominate, and the balance sheet is the one area of clear comfort. Versus deep dive #1 (68, old method), the fall is mostly methodological: the new method weighs the funded balance sheet and the near-elimination of warrants. Against that, three items found this run raise execution and governance risk:

  • the low-grade stockpile;
  • the "not effective" disclosure controls;
  • the auditor change.

Conclusion

  • What kind of company this is: a start-up miner with one legacy cash-flow asset. What you are really betting on is two things:

    • that Sangdong reaches design output;
    • that Western governments keep tungsten scarce enough for its price to stay several times the 2024 level.

  • The 2–3 things that will decide the outcome:

    1. Sangdong's real throughput, grade and recovery in Q4-26 to Q2-27.
    2. Whether the Western price stays above ~US$2,000/mtu through the 2027 DFARS switch.
    3. Whether Phase II is built on a sensible budget and time.

  • Signposts:

    • Bull confirmed:
      • Q4-26 or Q1-27 Sangdong sales imply ≥150,000 mtu/yr annualised.
      • Recovery is disclosed at ≥80%.
      • The plant runs 24/7 by early 2027.
      • Platts CIF-US prints above Rotterdam.
      • Phase II capex is disclosed and mills are ordered on schedule.
    • Bull broken:
      • Sangdong is still below ~100,000 mtu/yr annualised by mid-2027.
      • Rotterdam APT is below US$1,500 for a quarter.
      • A restatement or delayed filing.
      • Phase II is pushed to 2028 or later, or an acquisition uses the convert cash.

  • Balanced verdict:

    • The strongest bull version: a built, permitted, long-life mine outside China, with a 21-year uncapped offtake, enough cash to double capacity, and a US legal deadline in 11 weeks that should keep demand for its product strong.
    • The strongest bear version: no operating numbers yet, low-grade feed, a management team that has missed every Sangdong date since 2022, weak controls and a new auditor. Its price depends on Beijing.
    • Today the evidence leans to "real asset, unproven operation". The policy tailwind looks durable through 2027, but the execution risk is front-loaded and still largely untested.
    • Interpretation: at ~US$12, the market has moved part of the way toward Goldman's cautious view. The next two quarterly reports matter more than any analyst target.

Open questions & data gaps

  • Sangdong data (most important): no throughput, mtu produced, recovery or unit cost has been published. Q3 results (expected ~2026-11-11, date not confirmed [42]) should give the first numbers.
  • The amended GTP formula: the July 2026 terms (payable %, floor, any fixed-price periods) are on SEDAR+ and were not read. This matters for how much of a future Western premium Almonty can keep.
  • Phase II and oxide capex: not found.
  • "Royalties" cost line: rose to C$6.97M in Q2 (16% of revenue). Not explained.
  • Insiders: whether the Black/D'Amato 5M-share Form 144 was executed is not found, because SEDI was not accessible.
  • No earnings-call transcripts found, so analyst Q&A concerns are unknown.
  • The MD&A's "minimum of 15 months" going-concern wording next to C$1.2B cash is unexplained.
  • The reported June 2026 local stoppage is UNCONFIRMED.
  • The status of the Delaware domestication (approved in 2025, still "under consideration") is not found.
Sources
  1. Annual Information Form FY2025 (40-F Ex. 99.1) — Almonty / SEC EDGAR — 2026-03-18 — https://www.sec.gov/Archives/edgar/data/1670061/000149315226011503/ex99-1.htm
  2. Q2 2026 results release (6-K Ex. 99.1) — Almonty / SEC EDGAR — 2026-08-11 — https://www.sec.gov/Archives/edgar/data/0001670061/000149315226037264/ex99-1.htm
  3. Q2 2026 MD&A (6-K Ex. 99.3) — Almonty / SEC EDGAR — 2026-08-11 — https://www.sec.gov/Archives/edgar/data/1670061/000149315226037264/ex99-3.htm
  4. Q2 2026 interim financial statements (6-K Ex. 99.2) — Almonty / SEC EDGAR — 2026-08-11 — https://www.sec.gov/Archives/edgar/data/0001670061/000149315226037264/ex99-2.htm
  5. FY2025 MD&A (40-F Ex. 99.3) — Almonty / SEC EDGAR — 2026-03-18 — https://www.sec.gov/Archives/edgar/data/1670061/000149315226011503/ex99-3.htm
  6. Form F-10 prospectus (material contracts) — Almonty / SEC EDGAR — 2025 — https://www.sec.gov/Archives/edgar/data/1670061/000164117225017947/formf-10.htm
  7. GTP offtake amendment release — Almonty / SEC EDGAR — 2026-07-14 — https://www.sec.gov/Archives/edgar/data/0001670061/000149315226033123/ex99-1.htm
  8. Almonty commences processing operations at Sangdong — Almonty / SEC EDGAR — 2026-07-01 — https://www.sec.gov/Archives/edgar/data/0001670061/000149315226031435/ex99-1.htm
  9. Shareholder letter and corporate update — Almonty / SEC EDGAR — 2026-09-29 — https://www.sec.gov/Archives/edgar/data/1670061/000149315226044777/ex99-1.htm
  10. Almonty Industries at 20th International Investment Forum (transcript) — Investing.com — 2026-10-07 — https://www.investing.com/news/transcripts/almonty-industries-at-20th-international-investment-forum-sangdong-turns-to-output-93CH-4937657
  11. Convertible senior notes pricing — Almonty / SEC EDGAR — 2026-06-04 — https://www.sec.gov/Archives/edgar/data/1670061/000149315226027390/ex99-1.htm
  12. US$300M share repurchase programme — Almonty / SEC EDGAR — 2026-08-17 — https://www.sec.gov/Archives/edgar/data/1670061/000149315226038655/ex99-1.htm
  13. Notice of change of auditor — Almonty / SEC EDGAR — 2026-09-29 — https://www.sec.gov/Archives/edgar/data/1670061/000149315226044963/ex99-1.htm
  14. Los Santos tailings offtake with WBH (Sandvik) — Almonty / SEC EDGAR — 2026-09-17 — https://www.sec.gov/Archives/edgar/data/1670061/000149315226043044/ex99-1.htm
  15. Sangdong final operating certification — Almonty / SEC EDGAR — 2026-09-21 — https://www.sec.gov/Archives/edgar/data/1670061/000149315226043476/ex99-1.htm
  16. Phase 1 completion release — Almonty / SEC EDGAR — 2026-03-16 — https://www.sec.gov/Archives/edgar/data/1670061/000149315226010195/ex99-1.htm
  17. US headquarters in Dillon, Montana — Almonty / SEC EDGAR — 2026-04-13 — https://www.sec.gov/Archives/edgar/data/1670061/000149315226016286/ex99-1.htm
  18. Appointment of CFO — Almonty / SEC EDGAR — 2026-05-06 — https://www.sec.gov/Archives/edgar/data/1670061/000149315226021555/ex99-1.htm
  19. Form 144 (Lewis Black / Almonty Partners LLC) — SEC EDGAR — 2026-03-23 — https://www.sec.gov/Archives/edgar/data/1670061/000149315226012214/xsl144X01/primary_doc.xml
  20. Form 144 (Daniel D'Amato / Almonty Partners LLC) — SEC EDGAR — 2026-03-23 — https://www.sec.gov/Archives/edgar/data/1670061/000149315226012213/xsl144X01/primary_doc.xml
  21. Schedule 13G (Plansee / GTP Europe) — SEC EDGAR — 2026-06-17 — https://www.sec.gov/Archives/edgar/data/1670061/000121390026069610/xslSCHEDULE_13G_X02/primary_doc.xml
  22. Pure Tungsten corrective disclosure — Almonty / SEC EDGAR — 2026-10-02 — https://www.sec.gov/Archives/edgar/data/1670061/000149315226045665/ex99-1.htm
  23. Rwanda partnership — Almonty / SEC EDGAR — 2026-09-14 — https://www.sec.gov/Archives/edgar/data/1670061/000149315226042480/ex99-1.htm
  24. Mineral Commodity Summaries 2026: Tungsten — USGS — 2026-02 — https://pubs.usgs.gov/periodicals/mcs2026/mcs2026-tungsten.pdf
  25. One Market, Two Prices: the structural deadlock in the tungsten market — SMM — ~2026-10-09 — https://news.metal.com/newscontent/104148615-smm-tungsten-analysis-one-market-two-prices-how-to-break-the-structural-deadlock-in-the-tungsten-market
  26. September APT operating rate hits new low — SMM — 2026-09-30 — https://news.metal.com/newscontent/104141932-multiple-pressures-constrain-september-apt-industry-operating-rate-to-a-new-low-smm-tungsten-analysis
  27. Tungsten 2026: Geopolitics sets global tone — Fastmarkets — 2026-03-18 — https://fastmarkets.com/insights/tungsten-2026-geopolitics-sets-global-tone
  28. DFARS 225.7018-2 Restriction — acquisition.gov — accessed 2026-10-10 — https://www.acquisition.gov/dfars/225.7018-2-restriction.
  29. 10 U.S.C. 4872 — Cornell LII — accessed 2026-10-10 — https://www.law.cornell.edu/uscode/text/10/4872
  30. DPAS allocation order for recoverable critical minerals (FR Doc 2026-16078) — BIS / Federal Register — 2026-08-06 — https://public-inspection.federalregister.gov/2026-16078.pdf
  31. DoW invests in Elmet; DLA US$2B tungsten IDIQ — Manufacturing Dive — 2026-09-15 — https://www.manufacturingdive.com/news/dod-war-elmet-group-tungsten-supply-chain-dla-economic-defense-unit/830331/
  32. Platts proposes new alternative-supply-chain tungsten assessments (summary only, page returned 403) — S&P Global — 2026-08-28 — https://www.spglobal.com/energy/en/pricing-benchmarks/our-methodology/subscriber-notes/082826-platts-proposes-new-alternative-supply-chain-tungsten-price-assessments
  33. MSR delivers record Q1 profit — Masan High-Tech Materials — 2026-05-07 — https://masanhightechmaterials.com/msr-delivers-record-q1-profit-expanding-growth-headroom-for-2026/
  34. Jiaxin International Resources FY2025 results — HKEXnews — 2026-03-25 — https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0325/2026032501805.pdf
  35. ALM insider transactions (aggregator; Kwon lots) — TipRanks / Yahoo Finance — accessed 2026-10 — https://www.tipranks.com/stocks/alm/ownership
  36. Sangdong mine eyes role in securing tungsten for chip industry — Korea Times — 2026-08-22 — https://www.koreatimes.co.kr/business/companies/20260822/sangdong-mine-eyes-role-in-securing-tungsten-for-chip-industry
  37. Trump and Xi buy two more months of trade truce — investinglive — 2026-09-24 — https://investinglive.com/news/trump-and-xi-buy-two-more-months-of-trade-truce-leaving-tariffs-and-rare-earths-in-limbo/
  38. Goldman Sachs initiates Almonty at Neutral — Investing.com — 2026-09-24 — https://www.investing.com/news/analyst-ratings/goldman-sachs-initiates-almonty-industries-stock-at-neutral-93CH-4914636
  39. Jefferies initiates Almonty with Buy — Investing.com — 2026-09-02 — https://www.investing.com/news/analyst-ratings/jefferies-initiates-almonty-industries-stock-with-buy-on-tungsten-supply-93CH-4885501
  40. Stifel starts Almonty with US$25 PT — Yahoo Finance / Investing.com — 2026-09-25 — https://finance.yahoo.com/markets/stocks/articles/stifel-starts-almonty-25-price-141807347.html
  41. Jefferies, Goldman, now Stifel: Wall Street races to cover Almonty — ZeroHedge — 2026-09-25 — https://www.zerohedge.com/markets/jefferies-goldman-now-stifel-wall-street-races-cover-almonty-owning-bottlenecks-theme-gains
  42. Almonty pulls back while shorts dig in — Ortex — 2026-09-19 — https://ortex.news/articles/168099/almonty-pulls-back-while-shorts-dig-in
  43. Call-option volume, analyst table and price for ALM — The Cerbat Gem — 2026-10-10 — https://thecerbatgem.com/2026/10/10/investors-purchase-large-volume-of-call-options-on-almonty-industries-nasdaqalm.html
  44. Almonty's tungsten bonanza meets insider exodus — ad-hoc-news — 2026-07-13 — https://www.ad-hoc-news.de/boerse/news/ueberblick/almonty-s-tungsten-bonanza-meets-insider-exodus-227m-in-sales-cloud/69758328
  45. Almonty: Bank of America erwartet 670 Millionen — Börse Express — 2026-05-14 — https://www.boerse-express.com/news/articles/almonty-bank-of-america-erwartet-670-millionen-904938
  46. Almonty-Aktie: Diamond-Analyse (estimate cut) — Kapitalmarktexperten — 2026-08 — https://www.kapitalmarktexperten.de/almonty-aktie-1155-prozent-crash-trotz-diamond-analyse/
  47. Forum post citing Gangwon Domin Ilbo on June stoppage (LEAD ONLY, UNCONFIRMED) — Nordnet — 2026-06 — https://www.nordnet.dk/aktier/kurser/almonty-industries-alm-xnas
  48. EQ Resources record revenue in July 2026 (Barruecopardo output) — Kalkine Media — 2026-09 — https://kalkinemedia.com/au/news/announcements/eq-resources-achieves-record-a51-million-revenue-in-july-2026-driven-by-surge-in-tungsten-production
  49. European tungsten producer Almonty advances Korean Sangdong project — Northern Miner — 2020 — https://www.northernminer.com/news/european-tungsten-producer-almonty-advances-korean-sangdong-project/1003827695/
  50. ALM analyst forecasts (aggregators) — StockAnalysis / Chartmill — accessed 2026-10 — https://stockanalysis.com/stocks/alm/forecast/
  51. Almonty reverses 30% slide after Sangdong certification — Basisreport — 2026-09-21 — https://www.basisreport.com/news/alm-almonty-gap-after-sangdong-certification
All ALM Bulls vs Bears reports
Disclaimer. AI-generated research and podcast (Claude by Anthropic, voices by Google Gemini) for educational purposes — not financial advice and not a recommendation to buy or sell. Willem (MR.INVEST) owns this stock. Check the company’s own filings before making any decision.
← All Bulls vs Bears reports